Novo Nordisk Inc, et al v. United States HHS, et al
| NOVO NORDISK INC and NOVO NORDISK PHARMA INC |
| UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES, SECRETARY UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES, GENERAL COUNSEL UNITED STATES DEPARTMENT OF HEALTH HUMAN SERVICES, HEALTH RESOURCES SERVICES ADMINISTRATION and ADMINISTRATOR OF THE HEALTH RESOURCES SERVICES ADMINISTRATION |
| 21-3168 |
| November 26, 2021 |
| U.S. Court of Appeals, Third Circuit |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 29, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 14
ORDER (Clerk) In the plaintiffs' appeals (Nos. 21-3167 and 21-3168), briefing schedules were issued on December 17, 2021. Thereafter, the defendants filed cross-appeals (No. 21-3379 and 21-3380). The previously issued briefing schedules are VACATED. New briefing schedules will be issued at the appropriate time after all appeals and cross-appeals are ready for briefing. [21-3167, 21-3168, 21-3380, 21-3379] (CJG) [Entered: 12/29/2021 12:32 PM]
|
| Filing 13 ECF FILER: ENTRY OF APPEARANCE from Graciela M. Rodriguez on behalf of Appellant(s) Novo Nordisk Inc.; Novo Nordisk Pharma, Inc.. [21-3168] (GMR) [Entered: 12/17/2021 11:12 AM] |
| Filing 12 BRIEFING NOTICE ISSUED. Brief on behalf of Appellants Novo Nordisk Inc and Novo Nordisk Pharma Inc due on or before 01/26/2022. Appendix due on or before 01/26/2022. [-VACATED Pursuant to Clerk's 12/29/21 Order.]--[Edited 12/29/2021 by CJG] (PDB) [Entered: 12/17/2021 10:24 AM] |
| Filing 11 ECF FILER: ENTRY OF APPEARANCE from Daniel Aguilar on behalf of Appellee(s) HHS, Secretary of HHS, General Counsel of HHS, HRSA, Administrator of HRSA. [21-3168] (DJA) [Entered: 12/13/2021 05:34 PM] |
| Filing 10 FOLLOW UP LETTER to Jody D. Lowenstein, Esq. for HHS, Secretary United States Department of Health and Human Services, General Counsel United States Department of Health Human Services, Health Resources Services Administration and Administrator of the Health Resources Services Administration requesting the following document(s): Appearance Form on or before 12/27/2021. (LMR) [Entered: 12/13/2021 09:15 AM] |
| Filing 9 ECF FILER: Transcript Purchase Order Form (Part 1) filed by Appellants Novo Nordisk Inc and Novo Nordisk Pharma Inc advising this court that no transcripts are available. [21-3168] (ID) [Entered: 12/10/2021 07:01 PM] |
| Filing 8 ECF FILER: DISCLOSURE STATEMENT on behalf of Appellants Novo Nordisk Inc and Novo Nordisk Pharma Inc. [21-3168] (ACP) [Entered: 12/10/2021 06:54 PM] |
| Filing 7 ECF FILER: Concise Summary of the Case filed by Appellants Novo Nordisk Inc and Novo Nordisk Pharma Inc. [21-3168] (ACP) [Entered: 12/10/2021 06:52 PM] |
| Filing 6 ECF FILER: CIVIL INFORMATION STATEMENT on behalf of Appellants Novo Nordisk Inc and Novo Nordisk Pharma Inc. [21-3168] (ACP) [Entered: 12/10/2021 06:51 PM] |
| Filing 5 ECF FILER: ENTRY OF APPEARANCE from Israel Dahan on behalf of Appellant(s) Novo Nordisk Inc.; Novo Nordisk Pharma, Inc.. [21-3168] (ID) [Entered: 12/10/2021 06:45 PM] |
| Filing 4 ECF FILER: ENTRY OF APPEARANCE from Ashley C. Parrish on behalf of Appellant(s) Novo Nordisk Inc.; Novo Nordisk Pharma, Inc.. [21-3168] (ACP) [Entered: 12/10/2021 06:43 PM] |
| Filing 3 CLERK ORDER The appeals are hereby consolidated for purposes of scheduling, joint appendix, Appellees brief, and disposition. Appellants are encouraged to consult with one another regarding the contents of their briefs as the Court disfavors repetitive briefs. Appellants may file a consolidated brief or join in or adopt portions by reference. See Fed. R. App. P. 28(i). The parties are hereby directed to electronically file documents on the Courts docket as follows: Appellants: All case opening forms, motions, and briefs must be filed only in the appeal number assigned to the filers notice of appeal. If a document is being filed jointly by multiple appellants, the document must be filed only in the appeal numbers assigned to the filing appellants. Appellees. All case opening forms must be filed in all appeals in which the appellees intend to participate. All motions should be filed only in those cases for which the relief is being requested. Appellees consolidated brief must be filed in all appeals to which the appellees are responding. The consolidated joint appendix must be filed in all appeal numbers. [21-3167, 21-3168] (PDB) [Entered: 11/26/2021 01:45 PM] |
| Filing 2 RECORD available on District Court CM/ECF. (PDB) [Entered: 11/26/2021 01:40 PM] |
| Filing 1 CIVIL CASE DOCKETED. Notice filed by Appellants Novo Nordisk Inc and Novo Nordisk Pharma Inc in District Court No. 3-21-cv-00806. (PDB) [Entered: 11/26/2021 01:36 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
